Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in AVBP — ArriVent BioPharma, Inc.

CIK 1595888 NEW YORK, NY
Back to AVBP Full portfolio

Position in AVBP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$407,370 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
6 quarters on record

Common Shares in AVBP Over Time

Shares Held

Position Value (USD)

Derivatives in AVBP

reported options exposure · as of Jun 30, 2026
CallValue
$4,811,490
CallShares
138,500
PutValue
$239,706
PutShares
6,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in AVBP

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $239,706 6,900
2026-06-30 $4,811,490 138,500
2026-03-31 $1,278,078 55,400
2026-03-31 $407,370 17,658
2026-03-31 $1,148,886 49,800
2025-12-31 $2,077,490 103,255
2024-09-30 $249,710 10,626
2024-06-30 $284,426 15,333
2024-03-31 $660,086 36,959